key: cord-0277002-88jrj4it
authors: Gupta, A.; Basu, R.; Bashyam, M. D.
title: Monitoring SARS-CoV-2 genome evolution in a localized population
date: 2022-01-21
journal: nan
DOI: 10.1101/2022.01.19.22269572
sha: 60be2545d1615da11ffcd8cc306209c14e638c65
doc_id: 277002
cord_uid: 88jrj4it

Despite seminal advances towards understanding its infection mechanism, SARS-CoV-2 continues to cause significant morbidity and mortality worldwide. Though mass immunization programs have been implemented in several countries, the viral transmission cycle has shown a continuous progression in the form of multiple waves. A constant change in the frequencies of dominant viral lineages, arising from the accumulation of nucleotide variations (NVs) through favourable selection, is understandably expected to be a major determinant of disease severity and possible vaccine escape. Indeed, worldwide efforts have been initiated to identify specific virus lineage(s) and/or NVs that may cause a severe clinical presentation or facilitate vaccination breakthrough. Since host genetics is expected to play a major role in shaping virus evolution, it is imperative to study role of genome-wide SARS-CoV-2 NVs across various populations. In the current study, we analysed the whole genome sequence of 3543 SARS-CoV-2 infected samples obtained from the state of Telangana, India (including 210 from our previous study), collected over an extended period from April, 2020 to October, 2021. We present a unique perspective on the evolution of prevalent virus lineages and NVs during this time period. We also highlight presence of specific NVs likely to be associated favourably with samples classified as vaccination breakthroughs. Finally, we report genome-wide intra-host variations (iSNVs) at novel genomic positions. The results presented here provide critical insights into virus evolution over an extended time period within a geographically restricted area and pave the way to rigorously investigate the role of specific NVs in vaccination breakthroughs.

In December 2019, a local outbreak of multiple cases of acute pneumonia (later classified as coronavirus disease (COVID-19, https://www.who.int/news-room/q-adetail/coronavirus-disease-covid-19)) was reported in Wuhan, Hubei province, China, caused by a novel coronavirus called as Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2). The outbreak was soon followed by a rapid worldwide transmission which led to World Health Organization (WHO) declaring COVID-19 as a global pandemic in January, 2020. The rapid transmission rate of SARS-CoV-2 has resulted in 281,808,270 infections and >5 million deaths worldwide (as per WHO statistics, collected till December 29, 2021) . More importantly, the last one year witnessed the emergence of multiple virus variants [1, 2] , of which five were classified as Variants of Concern (VoCs) by the WHO (https://www.who.int/en/activities/tracking-SARS-CoV-2-variants/) based on their higher transmissibility [3] [4] [5] [6] and/or enhanced ability to escape neutralization by antibodies [7] [8] [9] [10] [11] [12] . Of the five, the B.1.617.2 lineage (designated (and hereinafter mentioned) as 'Delta' by the WHO) has exhibited maximum transmission during the past one year making it the predominant viral form present worldwide [13] . As SARS-CoV-2 continues to evolve into distinct lineages, with potentially increased pathogenicity and/or transmission abilities, it becomes imperative to study the emerging genomic variants.

The current study was initiated to analyse the sequences generated from SARS-CoV-2 infected samples, collected over a course of 19 months from the state of Telangana, India. We present the major trends of dominant lineages propagating in Telangana and corresponding trends in other pan-Indian regions and worldwide, across this time period. We also report a comprehensive map of all nucleotide variations (NVs) in the viral genome during this period and their possible association with vaccine escape. Finally, we have analysed specific virus genomic positions involved in generating intra-host diversity.

Biotech Ltd, India (Table S1A-C). The vaccine identity was unknown for 49 samples.

The vaccination dates were unavailable for 12 partially vaccinated and 2 completely vaccinated cases and therefore these 14 samples were excluded during NV analysis of vaccination breakthrough cases For a pan-India and worldwide analyses of widespread lineages, a dataset comprising of 31546 (India) and 678438 (world) consensus genomes (fasta files) for the period March 2021 to October, 2021 were accessed from the publicly available Global Initiative on Sharing All Influenza Data [20] (GISAID, https://www.gisaid.org/) repository; accession IDs for all the sequences submitted to GISAID, from this study are listed in Table S2 .

Total RNA was isolated in a Biosafety level 2 (BSL-2) environment following standard protocols using the RNA isolation kit (MagRNA-II Viral RNA Extraction Kit, States) and fragment sizes were analyzed in Agilent Tapestation 4200 (Agilent Technologies Inc., Santa Clara, California, United States). The pooled library was further normalized to 10nM concentration and 10μl of each normalized pool containing index adapter set A, B, C, and D were combined in a new microcentrifuge tube to a final concentration of 2nM. The pooled libraries were denatured and sequencing was performed on Nextseq 2000 using the P2 100 Cycle kit with 1x101bp Sequencing chemistry. About 50-100Mb data was generated for each sample.

The raw sequencing data in fastq format was subjected to quality checks including filtering bad quality reads, determination of sequencing depth and adapter trimming using Trimmomatic [21] . All reads shorter than 30 bases or with a Phred quality score <20, were discarded. 18 samples were rejected because of low overall sequencing depth and poor quality. The trimmed reads were then aligned to the reference Wuhan sequence (NCBI ID -NC_045512.2) using bwa-mem [22] algorithm. Post alignment filtering and quality assessment was performed using samtools [23] . Single nucleotide variants (SNVs) were identified using iVar [24] which works on the mpileup output from samtools. The variants were annotated using SnpEff [25] and further filtered to remove all problematic sites documented to be prone to accumulate sequencing errors by multiple sources as recommended earlier (https://virological.org/t/issues-with-sars-cov-2-sequencing-data/473). Sequences with high coverage, low N content, and associated with complete metadata were included for further analysis. Reads were assembled to generate consensus fasta file using samtools mpileup and the consensus module of iVar with a base assigned as consensus if it had a minimum depth of at least 10 reads (setting ivarMinDepth=10). Sequences where the N content was > 30% and sequence length < 27,000 were rejected. Lineage assignment was done on consensus fasta files using Pangolin [26] version (v3.1.16).

All alleles with an allele frequency of >90% were classified as NVs. For analysis of NV cross-correlation, a methodology similar to the one reported in our previous study [14] , was used. Briefly, a binary matrix was constructed for each sample with all NVs found in >5% samples as columns, indicating whether an NV of interest was present or absent in a sample. NVs exhibiting low standard deviation across samples were not included in the analysis. Pairwise Pearson correlation coefficients were estimated for this binary matrix using cor function in R. p-values indicating significance of association between each pairwise correlation coefficient was estimated using the cor.test function with chi-square test. This matrix was then used to visualize the NV cross-correlation maps in R corrplot function [27] . Odds ratio for estimating the association likelihoods of genomic alterations with vaccination breakthrough cases were estimated by creating contingency matrices for each NV identified in >5% of vaccinated samples and were compared with multiple random subsamples of non-vaccinated cases starting March 2021 onwards.

The estimation of intra-host Single Nucleotide Variations (iSNVs) was carried out using Lofreq [28] , a variant caller with a high sensitivity to predict iSNVs with an allele frequency as low as 1% [28] . The minor alleles with allele frequencies between 2% and 50%, and minimum sequencing depth of 100x, were classified as iSNVs, and were used for further analysis.

All statistical tests and analyses were performed using custom R scripts. All is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. [26] and pangoLEARN [29] ). December, 2020, witnessed the emergence of is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. ; https://doi.org/10.1101/2022.01.19.22269572 doi: medRxiv preprint major Delta sub-lineages observed in Telangana (Figure 1a) , though the fraction of Delta sub-lineages was higher in most Indian states compared to Telangana ( Figure   S1b ). Moreover, the major sub-lineages in other states varied from July 2021 onwards ( Figure S1b ).

The distribution of Delta sub-lineages also differed worldwide (Figure 1c) . 

NVs coinciding with the second wave Study of independent NVs, which may not be included as part of the NV signature of a lineage, and could have arisen due to positive selection, may be critical from the perspective of public health surveillance. A monthly assessment revealed a significant shift in the NVs observed in Telangana during the course of last one year ( Figure S2 ). Overall, a few NVs were consistently present in the population starting from April, 2020, namely A23403G (D614G, S), C241T, C3037T (P924F, ORF1a: nsp3), and C14408T (P4720L, ORF1b: nsp12) ( Figure S2 ). Genes coding for envelope and membrane proteins (E and M genes, respectively) and the accessory protein ORF6, remained relatively free from high frequency NVs till October 2021.

The genomic landscape of the virus was marked by the presence of few high frequency NVs in the period from April, 2020 to July, 2020 ( Figure S2 ). The period from August, 2020 to February, 2021 witnessed appearance and subsequent . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. ; disappearance of many moderately frequent NVs, especially in ORF1ab. However, March, 2021 onwards, a larger number of NVs became evident at moderate to high frequencies throughout the genome ( Figure S2 ). Specifically, the S protein, nucleocapsid (N), ORF7a/b, and nsp3 accumulated several missense NVs ( Figure   2 ). The S protein NVs included T19R, T95I, G142D, del156-157, A222V, L452R, T478K, D614G, P681R, and D950N, along with the ubiquitous D614G ( Figure 2 ). is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. ; https://doi.org/10.1101/2022.01.19.22269572 doi: medRxiv preprint T120I (7a), and T40I (7b) from January 2021 (Figures 2 and S3) . Similarly, the NV landscape of ORF3a was significantly altered post-December, 2020 and ORF1b:nsp12 (RNA dependent RNA polymerase) accumulated the G5068S NV in addition to the ubiquitously present P4720L ( Figure S4 ). The frequencies of all these NVs in ORF7a/b, ORF3a, and nsp12, were consistently high in samples classified as either Delta or its sub-lineages AY.20 , AY.39, and AY.44, potentially reflecting an extended genomic variation footprint not observed in previous lineages ( Figures S3,   S4 ). Furthermore (and similar to the observations made with respect to lineages), an inspection of the NVs in the samples collected from two local 'super-spreader' events (Table S1A ) did not reveal enrichment of any specific NVs.

In a nutshell, the Delta sub-lineages were marked by presence of several NVs, over and above those that defined the Delta. Secondly, AY.20 and AY.39 had relatively higher numbers of NVs compared to other sub-lineages observed in the state. Since the emergence of vaccine breakthrough cases coincided roughly with emergence of Delta and its sub-lineages, we proceeded to investigate whether the lineages or the NVs associated with them, showed a higher likelihood of occurrence in vaccination breakthrough cases.

A large fraction (70%) of vaccination breakthrough cases belonged to the Delta lineage, followed by AY.44 (5.2%), AY.20, AY.43, and AY.39 (5% each) ( Figure   S1d ). Interestingly, 57%, 39%, 29%, and 22% of all samples classified as AY.32, AY.43, AY.35, and AY.20 respectively, belonged to vaccination breakthrough cases ( Figure S1d ). We next analysed all S protein NVs present in >3% of vaccinated cases. T19R, deletion EFR156G (156-157del), L452R, T478K, D614G, P681R, and D950N, present in high frequency in the total dataset, were also present with highest frequencies (>80%) in vaccinated cases ( Figure S5 ), as expected. In addition to these, T95I, which was found to be present in slightly higher frequencies in samples belonging to AY.20 compared to the Delta, was found in 50.8% of all vaccinated samples. Another S protein alteration V1104L (located in the S2 subunit), was present in ~7.5% of all vaccinated cases. Intriguingly, frequency of this NV was higher in AY.20 associated samples than in Delta itself ( Figure S3) . A separate analyses of partial and completely vaccinated cases identified S221A (2.3% cases)

. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. as an exclusive event in completely vaccinated cases (Figure 3a) . Similarly, T1117I (~3.9% cases) and H1101Y (~1.9% cases), were identified exclusively in partially vaccinated cases (Figure 3a) . We computed odds ratios to estimate significance of association of genome-wide NVs with vaccination breakthrough cases. V1104L (S), S26L (ORF3a), V82A (ORF7a), R203M (N), and T3646A (ORF1ab) exhibited odds ratios ranging between 1.5-3.0 (p-value < 0.05, at 95% confidence interval ( Figure   3b ); details of upper and lower confidence interval limits are provided in supplementary Table S4 ), thereby providing further support towards favourable occurrence of these NVs in vaccination breakthrough cases is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. We extended the analysis to vaccine breakthrough cases and observed a positive cross-correlation between S26L (ORF3a), P4720L (ORF1ab) and D614G (S) (correlation coefficient r 2 > 0.75) which was absent in non-vaccinated cases ( Figure   S6 ). Interestingly, S26L (ORF3a) also exhibited highly significant association with vaccination breakthrough cases (Figure 3b ). Another positive cross-correlation was observed among V82A (ORF7a) and S protein NVs, L452R, T478K (r 2 > 0.75, as opposed to r 2 < 0.75 in non-vaccinated Delta samples), and T19R, del156-157, T95I (r 2 > 0.5; < 0.5 in non-vaccinated cases). Finally, another instance of increased positive correlation in vaccination breakthrough cases was formed by R203M (N), V82A, T120I (ORF7a) compared to non-vaccinated cases ( Figure S6 ). This aligns well with our previous observation, where both R203M and V82A display favourable odds of occurrence in vaccination breakthrough cases (Figure 3b) . Overall, the findings suggest that the genomic alterations in S protein (L452R, T478K, P681R) which have previously been reported to increase escape from neutralizing antibodies and potentially associate with vaccination breakthroughs [7] , [10] is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint 

Since virus genomic diversity arises within a host, it becomes important to uncover minor alleles originating in the form of iSNVs. A total of 545 samples (15.4% of the total dataset) exhibited iSNVs of which a majority (234; 43% (6.6% of total dataset)) harboured minor allelic variants at a single genomic position and 165 samples (30% (4.6% of the total dataset)) exhibited iSNVs at two positions ( Figure 4a) .

Interestingly, 11 samples contained more than 9 sites with minor alleles. However, the Ct values in 7 of these 11 cases were > 22 (Table S5) indicating possible false calls due to sequencing error(s), as reported earlier [31] [32] [33] . Presence of >9 iSNVs sites in rest of the 3 samples could probably reflect mixed infections, as reported earlier [31] . N, nsp11, nsp9, and ORF3a exhibited higher frequency of iSNVs (when normalized to gene size) compared to other proteins (Table S6) .

We next endeavoured to map co-occurrence of NVs and iSNVs in the genome.

Across the 545 samples, a total of 229 genomic loci were involved in iSNVs, of which 113 loci were found to also share NVs (Figure 4b ). This observation stands in contrast to total number of genomic loci which formed NVs across the dataset is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. In addition, a few iSNVs exhibited a significant increase in sample frequency across a long time period, despite exhibiting an allele frequency of < 50% (Figure 4c) . A notable example being all alternative alleles at position 5270 (nsp3), which exhibited allele frequency <16%, but were nonetheless detected in a significant fraction of samples (across the 3543 samples, 5270A in 33% cases, 5270C in 20%, 5270G in 5%) (Figure 4c ). Another such instance was observed at position 29033 (N; 29033T in 6%, 29033A in 1.2%) (Figure 4c ). We next focused on S protein iSNVs, expected to be important in shaping virus transmission and immune escape. In addition, S protein iSNVs are reported to be rare events due to evolutionary constraints with many getting lost attesting to a narrow transmission bottleneck [34] . A few minor alleles 19I (C21618), 30H (A21650), 879S (G24197), 1101Y (C24863), 1118Y (C24914), and 1252C (C25317), which were first observed in independent samples in January 2021, were consistently present in samples till October 2021 as well (sample distribution and allele frequency shown in Figure 4c ). Among these, the S protein iSNVs associated minor alleles that exhibited an increased sample frequency from the time of their emergence were 30H, 1101Y, and 1252C; the distribution of their allelic frequencies in shown in Figure 4c . However, the allelic frequencies of 30H and 1252C, in all the samples in which they were detected, was < 50% (with the exception of one sample which harbored the 1252C allele at allele frequency > 75%). On the contrary, from June to September 2021, the sample frequency of 1101Y increased from 0.6% to 3%, with a concordant increase in corresponding allele frequency (Figure 4c) . Interestingly, the . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. ; https://doi.org/10.1101/2022.01.19.22269572 doi: medRxiv preprint H1101Y NV was also present in >5% of all partially vaccinated samples. Subsequent analysis on the potential functional impact of these iSNVs is currently underway.

. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. ; https://doi.org/10.1101/2022.01.19.22269572 doi: medRxiv preprint Discussion SARS-CoV-2 continues to cause significant morbidity and mortality worldwide making it important to perform regular genomic surveillance to detect emerging virus NVs. The estimated mutation rate of SARS-CoV-2 is about 1.1 × 10 −3 substitutions/site/year [35] . The constant virus evolution leading to emergence of new variants is shaped by several factors including host genetics and immune response [36] [37], strong selection pressure created due to neutralizing antibodies [38] , etc. The infection rate reduced significantly across India after peaking in August, 2020. However, India witnessed a ferocious 'second wave' of infection during February to June, 2021, with number of deaths several folds higher than that observed in the first wave [39] . The massive spread has mostly been attributed to the Delta variant, which has been shown to be associated with higher transmissibility rates than previously circulating Alpha and Kappa lineages [40] , [41] . The Delta rapidly displaced all previously circulating viral lineages owing perhaps to its increased fitness (R0 (Re) 60-70%) with viremia 1000 folds higher than most previous lineages [41] . The increased adaptability of a pathogen virus under 'waning' immune pressure or partial immunization, has been reported in other studies [42] . While other widely transmitted lineages such as the Alpha emerged in other countries before vaccination programs were implemented [5] , the countrywide spread of the Delta probably occurred during the implementation of vaccination in India. This suggests that higher mutation accumulation observed in this variant could be a result of increased selection pressure under a modified host microenvironment which the virus was exposed to. This suggestion assumes significance given the Delta variant's ultrafast replication speeds which makes it detectable within 4 days after exposure [41] . Despite the preponderance of Delta during the second wave, the spread of specific virus lineage(s)/sub-lineages did exhibit differences in various geographical regions within India. Under these circumstances, it becomes imperative to study the evolution of the virus within a specific demography over an extended is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. ; https://doi.org/10.1101/2022.01.19.22269572 doi: medRxiv preprint India and in different countries indicates a potential role of population-specific host genetic factors which might govern the favourable spread of one sub-lineage over another. We have however not evaluated the association between host genetics and viral sub-lineages in this study. Although there are multiple reports of the association of a few S protein NVs (especially T478K, P681R, and L452R) with viral transmissibility and immune escape [10] , [43] , we have performed an extensive analyses on the entire landscape of SARS-CoV-2 genomic NVs in this study.

Although these NVs have been reported to occur in samples belonging to Delta lineage (as documented in GISAID, and https://outbreak.info/situation-reports/delta), their association with vaccination breakthrough events were not reported thus signifying the importance of our analysis. However, absence of information on neutralization antibody levels in vaccinated individuals did make it difficult for us to establish a strong association with vaccination breakthrough cases. Also, keeping in mind the interpretation pitfalls that may be created due to the small size of vaccination breakthrough cases, we are currently validating the results presented here on a larger sample set.

The NV cross-correlation analysis is a powerful tool to establish moderately or tightly linked genome-wide signatures. Our analyses revealed the complete footprint of genomic alterations affiliated to specific viral lineages. The cross-correlation analysis not only described the entire set of alterations associated with Delta and its sublineages, but also revealed several NVs that were completely mutually exclusive with those associated with previously circulating lineages. Another significant observation made possible through the cross-correlation analysis was the preferential cooccurrence of specific NVs in Delta sub-lineages but absent from Delta itself; which could not be deduced from a linear analysis of NV timeline. The analyses also suggested higher enrichment of certain co-occurring NVs in vaccination breakthrough (compared to other) cases.

Previous studies have shed evidence on how iSNVs impart genomic plasticity [44] and direct viral genome evolution through inter-host transmission cycles [45, 46] . Due to lack of data on donor-recipient pairs and primary contacts (including family members) of infected individuals, we were unable to perform iSNV bottleneck estimation in this study. Moreover, despite having a substantial dataset size, the information output is hampered by lack of clinical information like infection is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint showing iSNVs and their vaccination status or their age or with a specific lineage (data not shown). Secondly, we identified specific iSNVs like the 25907T in ORF3a that exhibited increased sample and allele frequencies with time. Interestingly, the 172V alteration generated from 25907T has been shown to improve protein stability, owing to increased local hydrophobic interactions, in recent studies [47] . The stability of ORF3a, plays a crucial role in its functionality as an apoptosis inducing protein leading to cell death [48] and membrane rearrangement during SARS-CoV-2 infection [49] .

The iSNV analysis has potentially revealed an important S protein allele viz. 1101Y, where the 'Y' allele frequency showed an upward trend from April 2021 and was labelled as an NV as its frequency became >50%. Further, this NV was also preferentially associated with partially vaccinated samples. Interestingly, H1101Y, V1104L, and T1117I are located between the two heptapeptide repeat sequences HR1 and HR2 within the S2 subunit of the S protein ( Figure S8 ). Earlier reports have suggested that both V1104L and H1101Y could increase local stability and alter the surface character of the S protein, thereby aiding in favourable evolution of the virus [50, 51] . We therefore recommend to include H1101Y and V1104L under active surveillance.

This study provides fresh insights into how the virus genome landscape has evolved over the duration of 19 months in a localized population in India. The novelty of the study stems from its all all-inclusive approach and the identification of missense NVs in the context of cross-correlation and intra-host diversity analysis. More importantly, we laid greater emphasis on individual NVs rather than the lineages per se; given the recent and frequent 're-classifications' of SARS-CoV-2 lineages by Pangolin [29] . Our is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. ; 

All the raw sequencing data used in this study have been submitted to the Sequencing Read Archive (SRA) with project accession ID PRJNA691556. is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint Only those sub-lineages present in >5% of total sequences submitted from the region were included. In panels b) and c), while estimating frequencies for the Asian countries, Indian sequences were excluded.

. CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. ; https://doi.org/10.1101/2022.01.19.22269572 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. ; https://doi.org/10.1101/2022.01.19.22269572 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. ; https://doi.org/10.1101/2022.01.19.22269572 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. ; https://doi.org/10.1101/2022.01.19.22269572 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. ; https://doi.org/10.1101/2022.01.19.22269572 doi: medRxiv preprint is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. ; https://doi.org/10.1101/2022.01.19.22269572 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a perpetuity.

is the author/funder, who has granted medRxiv a license to display the preprint in (which was not certified by peer review) preprint

The copyright holder for this this version posted January 21, 2022. ; https://doi.org/10.1101/2022.01.19.22269572 doi: medRxiv preprint

Genomic characteristics and clinical effect of the emergent SARS-CoV-2 B.1.1.7 lineage in London, UK: a wholegenome sequencing and hospital-based cohort study

Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra

CMMID COVID-19 Working Group1 ‡, COVID-19 Genomics UK

Possible link between higher transmissibility of B.1.617 and B.1.1.7 variants of SARS-CoV-2 and increased structural stability of its spike protein and hACE2 affinity Biophysics

The COVID-19 Genomics UK

Covid-19: Delta variant is now UK's most dominant strain and spreading through schools

Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants

Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera Microbiology

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants

Moore PL & Sigal A (2021) SARS-CoV-2 Omicron has extensive but incomplete escape of Pfizer BNT162b2 elicited neutralization and requires ACE2 for infection Infectious Diseases (except HIV/AIDS)

Genetic emergence of B.1.617.2 in COVID-19

A comprehensive profile of genomic variations in the SARS-CoV-2 isolates from the state of Telangana

The Genotype to Phenotype Japan

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine

Data, disease and diplomacy: GISAID's innovative contribution to global health: Data, Disease and Diplomacy

Trimmomatic: a flexible trimmer for Illumina sequence data

Fast and accurate short read alignment with Burrows-Wheeler transform

The Sequence Alignment/Map format and SAMtools

An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar

A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Corrgrams: Exploratory Displays for Correlation Matrices

LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets

Pybus OG & Rambaut A (2021) Assignment of Epidemiological Lineages in an Emerging Pandemic Using the Pangolin Tool. Virus Evolution

SARS-CoV-2 variants of concern are emerging in India

Sanger Institute COVID-19 Surveillance Team (2021) Patterns of within-host genetic diversity in SARS-CoV-2

Pybus OG & Rambaut A (2021) Generation and transmission of interlineage recombinants in the SARS-CoV-2 pandemic

Temporal dynamics of SARS-CoV-2 mutation accumulation within and across infected hosts

The COVID-19 Genomics UK (COG-UK) consortium

Insights from SARS-CoV-2 sequences

The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity

Genetic variants of the human host influencing the coronavirus-associated phenotypes (SARS, MERS and COVID-19): rapid systematic review and field synopsis

SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma

Genomic characterization and epidemiology of an emerging SARS-CoV-2

Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and

Viral infection and transmission in a large

Unifying the Epidemiological and Evolutionary Dynamics of Pathogens

Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants

SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies

on behalf of the Oxford Virus Sequencing Analysis Group (OVSG)

SARS-CoV-2 within-host diversity and transmission

SARS-Cov-2 ORF3a: Mutability and function

SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis. mSystems

The ORF3a protein of SARS-CoV-2 induces apoptosis in cells

Structural Analysis of Spike Protein Mutations in the SARS-CoV-2 P.3 Variant Biophysics

Identification of twenty-five mutations in surface glycoprotein (Spike) of SARS-CoV-2 among Indian isolates and their impact on protein dynamics